Omico
A landmark Australian report by Omico will be launched tomorrow (25th Nov) at Parliament House showing that Australians with devastating cancer can have their lives extended when their tumour DNA is matched to advanced treatment, a process called precision oncology, which is simultaneously creating jobs and fuelling our economy.
Omico is Australia's not for profit leader in precision oncology. It's Impact Report: From Momentum to Mainstream shows:
- Australians matched to targeted treatment for their cancer lived up to 50% longer, from 14 to 21+ months, with survival more than doubling for some
- Omico initiatives have attracted more than $200 million to Australia, from direct foreign investment
- To date, Omico has created 1540+ new jobs, including in regional and Indigenous communities
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).
